Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...

Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...

Heather Cooper Ortner leads the International Myeloma Foundation, focusing on advancing research, improving patient access, and enhancing support for myeloma care. The International Myeloma Foundation ...

Panelists discuss how NCCN guidelines are expected to incorporate quadruplet-based regimens as reasonable treatment approaches for transplant-ineligible patients, while emphasizing the need for ...

Many of these advances are the result of decades of work and clinical trials. Since the mid-1990s, the American Cancer ...

Panelists discuss how quadruplet regimens show improved efficacy over triplet regimens without significantly increased safety concerns, with anti-CD38 antibodies being well tolerated and NCCN ...

To Jagannath, cure means long periods of disease-free survival as defined by minimal residual disease (MRD) criteria, 10 -5 ...

Using nationwide electronic health record (EHR) and cancer registry data from the VA Corporate Data Warehouse, we developed and validated a rule-based NLP algorithm to extract oncologist-determined MM ...

2025 MAY 26 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily-- New research on Oncology - Multiple Myeloma is the subject of a report. According to news ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Additional translational analyses demonstrated that patients receiving CARVYKTI ® in earlier lines had improved immune fitness, which suggests a correlation with longer progression-free survival (PFS) ...